Triptorelin Market Global Forecast to 2026

Triptorelin Market - Size, Share,
Outlook, and Opportunity Analysis,
2018 - 2026
Triptorelin Market, by Product Type (Triptorelin pamoate, Triptorelin
acetate, and Triptorelin embonate), by Application (Prostate Cancer,
Radical Prostatectomy, Endometriosis, Salivary Gland Cancer and
Central Precocious Puberty), By End User (Hospital Pharmacy, Retail
Pharmacy and Online Pharmacy) - Global Forecast to 2026
Gonadotropin-releasing hormone (GnRH) agonists have greater safety and efficacy profile than
estrogens and anti-androgens among various therapies of achieving medical castration.
Furthermore, slow-release formulations of GnRH agonists offer patients flexibility, improves
quality of life, and eventually reduce cost. Most of the times, prostate cancer progresses with
increasing testosterone hormone. Moreover, the production of testosterone can be stopped by
surgically removing the testicles or thorough medication therapy. Triptorelin is GnRH agonists
which is designed to stop the tentacles from making testosterone. This eventually reduces
testosterone levels and minimizes progression of prostate cancer.
Triptorelin is a decapeptide analogue of Luteinising Hormone-Releasing Hormone (LHRH, also
called gonadotropin-releasing hormone [GnRH]). Triptorelin is extensively used in palliative
treatment of hormone dependent advanced prostate cancer.
Request Sample Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/1963
Moreover, according to National Institute for Health and Care Excellence (NICE), in May 2013, the
licensed indications for luteinising hormone-releasing hormone (LHRH) agonist: triptorelin were
extended to include two new indications for prostate cancer: first in neoadjuvant treatment
before radiotherapy in high-risk localized or locally advanced disease and second in adjuvant
treatment to radical prostatectomy in locally advanced disease at high risk of progression.
Triptorelin is administrated intramuscularly or subcutaneously.
Furthermore, triptorelin is indicated for the treatment of pediatric patients two years of age and
older with Central Precocious Puberty (CPP). In July 2017, U.S. Food and Drug Administration
(FDA), approved Arbor Pharmaceuticals’: Triptodur, in pediatric patients with central precocious

puberty. The approval follows a phase 3 clinical trial (Efficacy, Safety, and Pharmacokinetics [PK]
of Triptorelin 6-month Formulation in Patients with Central Precocious Puberty), which examines
prepubertal luteinizing hormone levels using triporelin therapy. Study demonstrated a return to
pre-pubertal luteinizing hormone (LH) levels in 93% of enrolled patients, with pre-pubertal
luteinizing hormone (LH) suppression maintained at 12 months by 98% of patients.
Triptorelin is further being studied to analyze effects of adjuvant hormonal therapy treatments of
Tamoxifen, Letrozole and Letrozole + Zoledronate on bone loss in breast cancer patients.
According to ClinicalTrials.gov, in July 2017, this study was sponsored by National Cancer
Institute (NCI), Naples; and currently present in phase III clinical stage. Moreover, triptorelin
market shows lucrative revenue growth in the near future, with the successful completion of this
study and potential launch of new products during the forecast period.
Browse More About the Keyword Market Study @
https://www.coherentmarketinsights.com/market-insight/triptorelin-market-1963
Report includes chapters which deeply display the following deliverable about industry:
• Triptorelin Market Research Objective and Assumption
• Triptorelin Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Triptorelin Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Triptorelin Market, By Regions
• Triptorelin Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Triptorelin Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Triptorelin Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of
Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Triptorelin Market Forecast including Production, Consumption, Import and Export Forecast by Type,
Applications and Region.
• Research Findings and Conclusion
Table of Contents of Keyword Market Report:
1. Research Objective and assumption
2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis
4. Keyword Market, By Advanced Water Meters, 2017 - 2025 (USD Million)
5. Keyword Market, By Service, 2017 - 2025 (USD Million)
6. Keyword Market, By Solution, 2017 - 2025 (USD Million)
7. Keyword Market, By Regions, 2017 - 2025 (USD Million)
8. Competitive Landscape
Ask for Discount before Buying @
https://www.coherentmarketinsights.com/insight/request-discount/1963
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com